Last reviewed · How we verify
NCT05122832
Prevalence of NCD Risk Factors in Kazakhstan
trial testing Blood test in Non-Communicable Chronic Diseases in 20,400 participants. Completed in 20 August 2022.
20 August 2022
Quick facts
| Lead sponsor | Asfendiyarov Kazakh National Medical University |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 20,400 |
| Start date | 23 October 2021 |
| Primary completion | 20 August 2022 |
| Estimated completion | 20 August 2022 |
| Sites | 1 location across Kazakhstan |
Drugs / interventions tested
- Blood test — full drug profile →
- STEPwise Approach to NCD Risk Factor Surveillance (STEPS)
- Spirometry
Conditions studied
- Non-Communicable Chronic Diseases — all drugs for Non-Communicable Chronic Diseases →
Sponsor
Asfendiyarov Kazakh National Medical University
Who can join
Adults 18 to 69, any sex, with Non-Communicable Chronic Diseases. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This is a cross-sectional study that aims to study the prevalence of risk factors of noncommunicable diseases in people aged 18 to 69 years using the standardized and adopted STEPS questionnaire in the Republic of Kazakhstan.
Publications & conference data
8 peer-reviewed publications reference this trial (live from Europe PMC):
-
Assessment of hypercholesterolemia prevalence and its demographic variations in the Republic of Kazakhstan.
Kulimbet M, Davletov K, Saliev T, Davletov D, et al · · 2024 · cited 6× · PMID 38531935 · DOI 10.1038/s41598-024-57884-4 -
Evaluation of the sexual function of men in Kazakhstan during 2021-2022: A cross-sectional study.
Sikhymbaev M, Ospanova D, Grzhibovsky A, Akkaliyev M, et al · · 2023 · cited 3× · PMID 36865526 · DOI 10.1002/hsr2.1142 -
Sex differentials in the prevalence of behavioral risk factors and non-communicable diseases in adult populations of West Kazakhstan.
Baspakova A, Abitova AZ, Mussin NM, Kaliyev AA, et al · · 2024 · cited 2× · PMID 38420037 · DOI 10.3389/fpubh.2024.1333887 -
Prevalence of chronic kidney disease in Kazakhstan: evidence from a national cross-sectional study.
Nursultanova L, Kabulbayev K, Ospanova D, Tazhiyeva A, et al · · 2023 · cited 1× · PMID 37679536 · DOI 10.1038/s41598-023-42031-2 -
Association Between Socio-Demographic, Behavioural, and Health-Related Factors and Fruit, Vegetable, and Salt Consumption Among Adults Aged 18-69 Years in Kazakhstan: A Cross-Sectional Study.
Shoranov M, Ibrayeva A, Alchinbayev M, Sadykov B, et al · · 2026 · PMID 41978204 · DOI 10.3390/nu18071154 -
Physical Activity Levels in Kazakhstan: A Cross-Sectional Nationwide Study on Demographic, Socioeconomic, and Regional Factors.
Ibrayeva A, Shoranov M, Muminov T, Ismoldayev Y, et al · · 2025 · PMID 41303750 · DOI 10.3390/medicina61111913 -
Association between sociodemographic factors and alcohol consumption among adults aged 18-69 years in Kazakhstan: a cross-sectional study.
Ibrayeva A, Shoranov M, Alchinbayev M, Ramazanova B, et al · · 2025 · PMID 40374232 · DOI 10.1136/bmjopen-2024-094508 -
Prevalence and characteristics of tobacco use among adults in Kazakhstan: A cross-sectional National Survey.
Ibrayeva A, Shoranov M, Aipov R, Katarbayev A, et al · · 2025 · PMID 40129755 · DOI 10.1016/j.gloepi.2025.100194
Verify or expand the search:
- PubMed search for NCT05122832
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Blood test
Trials testing the same drug.
- NCT06863974 — High-throughput Omic Technology for Identification of Biomarkers of Relapsing Acute Disseminated Encephalomyelitis in Im · NA · recruiting
- NCT07078435 — Innate Immunity, MIcrobiota and Inovative Treatments in Endometriosis · NA · not yet recruiting
- NCT05370300 — SNAPS Breast Cancer Patient Study Breast Cancer Patients · not yet recruiting
- NCT06820450 — Pilot Study to Characterize the Endometriosis Steroidome and Its Link to Endocrine Disruptors and Vaginal Dysbiosis · not yet recruiting
- NCT06999785 — Assessment of the Impact of Increased Production of Reactive Oxygen Species Produced During Repeated Sessions of Hyperba · NA · recruiting
Other recruiting trials for Non-Communicable Chronic Diseases
Currently open trials in the same condition.
- NCT06581770 — Evaluation of Validity and Reliability of the Turkish Translation of the Digital Health Readiness Questionaire in Differ · recruiting
- NCT06387875 — Cohort in Qianwan New District, Ningbo · recruiting
Other Asfendiyarov Kazakh National Medical University trials
Trials by the same sponsor.
- NCT06953180 — Epigenetics and NCD Prevention in Kazakhstan: Personalized Approaches and Biological Age Prediction · recruiting
- NCT06496022 — Comparative Analysis of Risk Factors and Prediction of Frailty Syndrome · active not recruiting
- NCT05970861 — Effect of Natural Food on Gut Microbiome and Phospholipid Spectrum of Immune Cells in COVID-19 Patients · NA · completed
- NCT05095155 — Study of the Prognostic Role of Gene Polymorphism in the Development of B-cell Leukemias and Lymphomas in Children of Ka · completed
- NCT05090644 — Program for the Introduction Into Clinical Practice of the Principles of Personalized and Preventive Medicine Based on t · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05122832 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 9 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Asfendiyarov Kazakh National Medical University
- Last refreshed: 14 March 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05122832.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing